12:00 AM
Sep 21, 2009
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Excellair: Phase II started

ZaBeCor began a Phase II trial in patients.

ZaBeCor Pharmaceutical Co., Bala Cynwyd,...

Read the full 46 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >